Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Sutherland

Showing results (171-180 of 205) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|November 26, 2009
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalC A Barton, B S Gloss, W Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancerC J Ormandy, R E Hall, D L Manning, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongueR J Bova, D I Quinn, J S Nankervis, et al.
Cancer Research|December 26, 2001
Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasiaA V Biankin, J G Kench, A L Morey, et al.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
Pageof 21

Showing results (171-180 of 205) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|November 26, 2009
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalC A Barton, B S Gloss, W Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancerC J Ormandy, R E Hall, D L Manning, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongueR J Bova, D I Quinn, J S Nankervis, et al.
Cancer Research|December 26, 2001
Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasiaA V Biankin, J G Kench, A L Morey, et al.
British Journal of Cancer|July 3, 2008
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaT J Seng, N Currey, W A Cooper, et al.
Pageof 21